Search Results
Search for other papers by Misu Lee in
Google Scholar
PubMed
Search for other papers by Amelie Lupp in
Google Scholar
PubMed
Search for other papers by Nigel Mendoza in
Google Scholar
PubMed
Search for other papers by Niamh Martin in
Google Scholar
PubMed
Search for other papers by Rudi Beschorner in
Google Scholar
PubMed
Search for other papers by Jürgen Honegger in
Google Scholar
PubMed
Search for other papers by Jürgen Schlegel in
Google Scholar
PubMed
Search for other papers by Talia Shively in
Google Scholar
PubMed
Search for other papers by Elke Pulz in
Google Scholar
PubMed
Search for other papers by Stefan Schulz in
Google Scholar
PubMed
Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed
the effect of pasireotide on regrowth of clinically non-functioning pituitary adenomas (NFPAs) ( www.ClinicalTrials.gov ; identifier NCT01620138). Gonadotroph pituitary adenomas (GPAs) account for approximately 35% of all pituitary tumors. They are
Search for other papers by Odelia Cooper in
Google Scholar
PubMed
Search for other papers by George Vlotides in
Google Scholar
PubMed
Search for other papers by Hidenori Fukuoka in
Google Scholar
PubMed
Department of Medicine, Department of Medicine II, Department of Biomedical Science and Pathology and Laboratory Medicine, Department of Pathology and Laboratory Medicine, Pituitary Center, Cedars-Sinai Medical Center, Academic Affairs, Room 2015, 8700 Beverly Boulevard, Los Angeles, California 90048, USA
Search for other papers by Mark I Greene in
Google Scholar
PubMed
Search for other papers by Shlomo Melmed in
Google Scholar
PubMed
expression and function in gonadotroph adenomas. Overall, 75% of the 56 non-functioning adenomas tested express EGF either by IHC or by RT-PCR with rates varying between 10 and 100% in different series ( Chaidarun et al . 1994 a , Kontogeorgos et al . 1996
Search for other papers by Iain R Thompson in
Google Scholar
PubMed
Search for other papers by Annisa N Chand in
Google Scholar
PubMed
Search for other papers by Peter J King in
Google Scholar
PubMed
Search for other papers by Olaf Ansorge in
Google Scholar
PubMed
Search for other papers by Niki Karavitaki in
Google Scholar
PubMed
Search for other papers by Ceri Alexander Jones in
Google Scholar
PubMed
Search for other papers by Dolkun Rahmutula in
Google Scholar
PubMed
Search for other papers by David G Gardner in
Google Scholar
PubMed
Search for other papers by Vladimir Zivkovic in
Google Scholar
PubMed
Search for other papers by Caroline P Wheeler-Jones in
Google Scholar
PubMed
Search for other papers by Imelda M McGonnell in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Search for other papers by Richard A Anderson in
Google Scholar
PubMed
Search for other papers by John A H Wass in
Google Scholar
PubMed
Search for other papers by Alan S McNeilly in
Google Scholar
PubMed
Search for other papers by Robert C Fowkes in
Google Scholar
PubMed
gonadotroph and somatotroph adenoma paraffin-fixed samples were sectioned to 4 μm for analysis. Paraffin embedding was removed with Histoclear before subjecting the sections to antigen retrieval and immunohistochemistry for GC-B using a rabbit polyclonal
Department of Pharmacology, University of Alabama at Birmingham, Birmingham, Alabama, USA
Search for other papers by Graeme B Bolger in
Google Scholar
PubMed
Search for other papers by Mariana F Bizzi in
Google Scholar
PubMed
Search for other papers by Sergio V Pinheiro in
Google Scholar
PubMed
Search for other papers by Giampaolo Trivellin in
Google Scholar
PubMed
Search for other papers by Lisa Smoot in
Google Scholar
PubMed
Search for other papers by Mary-Ann Accavitti in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Search for other papers by Antonio Ribeiro-Oliveira Jr in
Google Scholar
PubMed
analysis of somatotroph, corticotroph, lactotroph, and clinically nonfunctioning gonadotroph adenomas as well as normal pituitary tissue. Normal pituitary architecture was evaluated by reticulin staining. After deparaffinization and hydrating procedures
Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Institut de Cancérologie Gustave-Roussy, Centre National de la Recherche Scientifique, Département de Génomique Fonctionnelle, Assistance Publique-Hôpitaux de Paris, Hôpital Foch, Service de Neurochirurgie, Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud 11, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre F-94275, France
Search for other papers by Françoise Galland in
Google Scholar
PubMed
Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Institut de Cancérologie Gustave-Roussy, Centre National de la Recherche Scientifique, Département de Génomique Fonctionnelle, Assistance Publique-Hôpitaux de Paris, Hôpital Foch, Service de Neurochirurgie, Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud 11, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre F-94275, France
Search for other papers by Ludovic Lacroix in
Google Scholar
PubMed
Search for other papers by Patrick Saulnier in
Google Scholar
PubMed
Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Institut de Cancérologie Gustave-Roussy, Centre National de la Recherche Scientifique, Département de Génomique Fonctionnelle, Assistance Publique-Hôpitaux de Paris, Hôpital Foch, Service de Neurochirurgie, Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud 11, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre F-94275, France
Search for other papers by Philippe Dessen in
Google Scholar
PubMed
Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Institut de Cancérologie Gustave-Roussy, Centre National de la Recherche Scientifique, Département de Génomique Fonctionnelle, Assistance Publique-Hôpitaux de Paris, Hôpital Foch, Service de Neurochirurgie, Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud 11, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre F-94275, France
Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Institut de Cancérologie Gustave-Roussy, Centre National de la Recherche Scientifique, Département de Génomique Fonctionnelle, Assistance Publique-Hôpitaux de Paris, Hôpital Foch, Service de Neurochirurgie, Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud 11, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre F-94275, France
Search for other papers by Geri Meduri in
Google Scholar
PubMed
Search for other papers by Michèle Bernier in
Google Scholar
PubMed
Search for other papers by Stéphane Gaillard in
Google Scholar
PubMed
Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Institut de Cancérologie Gustave-Roussy, Centre National de la Recherche Scientifique, Département de Génomique Fonctionnelle, Assistance Publique-Hôpitaux de Paris, Hôpital Foch, Service de Neurochirurgie, Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud 11, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre F-94275, France
Search for other papers by Jean Guibourdenche in
Google Scholar
PubMed
Search for other papers by Thierry Fournier in
Google Scholar
PubMed
Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Institut de Cancérologie Gustave-Roussy, Centre National de la Recherche Scientifique, Département de Génomique Fonctionnelle, Assistance Publique-Hôpitaux de Paris, Hôpital Foch, Service de Neurochirurgie, Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud 11, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre F-94275, France
Search for other papers by Danièle Evain-Brion in
Google Scholar
PubMed
Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Institut de Cancérologie Gustave-Roussy, Centre National de la Recherche Scientifique, Département de Génomique Fonctionnelle, Assistance Publique-Hôpitaux de Paris, Hôpital Foch, Service de Neurochirurgie, Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud 11, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre F-94275, France
Search for other papers by Jean Michel Bidart in
Google Scholar
PubMed
Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Institut de Cancérologie Gustave-Roussy, Centre National de la Recherche Scientifique, Département de Génomique Fonctionnelle, Assistance Publique-Hôpitaux de Paris, Hôpital Foch, Service de Neurochirurgie, Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud 11, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre F-94275, France
Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Institut de Cancérologie Gustave-Roussy, Centre National de la Recherche Scientifique, Département de Génomique Fonctionnelle, Assistance Publique-Hôpitaux de Paris, Hôpital Foch, Service de Neurochirurgie, Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud 11, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre F-94275, France
Search for other papers by Philippe Chanson in
Google Scholar
PubMed
features. Most NFPAs are gonadotroph adenomas expressing steroidogenic factor 1 ( Asa et al . 1996 , Al-Shraim & Asa 2006 ), required for differentiation of gonadotroph cells, and producing follicle-stimulating hormone (FSH)β and/or luteinizing hormone
Search for other papers by K Revill in
Google Scholar
PubMed
Search for other papers by K J Dudley in
Google Scholar
PubMed
Search for other papers by R N Clayton in
Google Scholar
PubMed
Search for other papers by A M McNicol in
Google Scholar
PubMed
Search for other papers by W E Farrell in
Google Scholar
PubMed
-localize with ∼40% of somatotrophs, ∼30% of corticotrophs, ∼50% of thyrotrophs, ∼30% of lactotrophs and ∼20% of gonadotrophs. NNAT expression status in pituitary adenomas A total of 47 pituitary adenomas were analysed by real-time RT-qPCR for NNAT transcript
Search for other papers by Audrey Ziverec in
Google Scholar
PubMed
Search for other papers by Marie Chanal in
Google Scholar
PubMed
Search for other papers by Perrine Raymond in
Google Scholar
PubMed
Endocrinology Department, “C.I. Parhon” National Institute of Endocrinology, Bucharest, Romania
Search for other papers by Mirela Diana Ilie in
Google Scholar
PubMed
Search for other papers by Dario De Alcubierre in
Google Scholar
PubMed
Search for other papers by Arja Pasternack in
Google Scholar
PubMed
Search for other papers by Olli Ritvos in
Google Scholar
PubMed
Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
Department of Endocrinology, Reference center for rare pituitary disease (HYPO), Groupement Hospitalier EST, Hospices Civils de Lyon, University of Lyon, Lyon, France
Search for other papers by Gerald Raverot in
Google Scholar
PubMed
Search for other papers by Philippe Bertolino in
Google Scholar
PubMed
.07.009 ) Chesnokova V Zonis S Wawrowsky K Tani Y Ben-Shlomo A Ljubimov V Mamelak A Bannykh S Melmed S 2012 Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth . Molecular Endocrinology 26 2092 – 2103 . ( https
Search for other papers by Cuong V Duong in
Google Scholar
PubMed
Search for other papers by Richard D Emes in
Google Scholar
PubMed
Search for other papers by Frank Wessely in
Google Scholar
PubMed
Search for other papers by Kiren Yacqub-Usman in
Google Scholar
PubMed
Search for other papers by Richard N Clayton in
Google Scholar
PubMed
Search for other papers by William E Farrell in
Google Scholar
PubMed
epimutations, methylation-mediated silencing of the MEG3 gene is a frequent finding in pituitary adenomas of gonadotroph origin whereas methylation-mediated silencing of the p16 gene ( CDKN2A ) is infrequent in somatotrophinomas but is a common finding in
Search for other papers by Maria P Yavropoulou in
Google Scholar
PubMed
Search for other papers by Marina Tsoli in
Google Scholar
PubMed
Search for other papers by Konstantinos Barkas in
Google Scholar
PubMed
Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
Search for other papers by Ashley Grossman in
Google Scholar
PubMed
factor 1; TPIT, T-box family member TBX19; TSH, thyroid stimulating hormone; WHO, World Health Organization. Subtypes of non-functioning PitNETs Non-functioning-silent gonadotroph adenomas Silent gonadotroph adenomas (sGAs) comprise the
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by Carolina Di Somma in
Google Scholar
PubMed
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Search for other papers by Gaetano Lombardi in
Google Scholar
PubMed
Search for other papers by Silvia Savastano in
Google Scholar
PubMed
secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist . Journal of Clinical Endocrinology and Metabolism 71 92 – 97 . Dekkers OM Hammer S de Keizer RJ Roelfsema F Schutte PJ Smit JW